Global Injectable Bone Graft Market Growth (Status and Outlook) 2025-2031

Global Injectable Bone Graft Market Growth (Status and Outlook) 2025-2031

The global Injectable Bone Graft market size is predicted to grow from US$ 689 million in 2025 to US$ 942 million in 2031; it is expected to grow at a CAGR of 5.3% from 2025 to 2031.

An injectable bone graft refers to a biomaterial that can be delivered in a fluid or paste-like form directly into a surgical site, typically to promote bone regeneration or fusion. These grafts are often used in orthopedic and dental procedures where there is a need to fill voids, defects, or gaps in bone tissue. Injectable bone grafts can contain various components such as ceramics, polymers, growth factors, or bone-derived materials that facilitate new bone formation and integration with existing bone structures. Their injectable nature allows surgeons to precisely place the graft material into complex or minimally invasive surgical sites, enhancing surgical outcomes and patient recovery.

Global key players of Injectable Bone Graft include Medtronic, DePuy Synthes, Baxter, Stryker (Wright Medical), BONESUPPORT, etc. The top five players hold a share about 60%. North America is the largest market, and has a share about 74%, followed by Europe and Asia-Pacific with share 18% and 5%, separately. In terms of product type, Synthetic is the largest segment, accounting for a share of 77%. In terms of application, Hospital is the largest field with a share about 66 percent.

LPI (LP Information)' newest research report, the “Injectable Bone Graft Industry Forecast” looks at past sales and reviews total world Injectable Bone Graft sales in 2024, providing a comprehensive analysis by region and market sector of projected Injectable Bone Graft sales for 2025 through 2031. With Injectable Bone Graft sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Injectable Bone Graft industry.

This Insight Report provides a comprehensive analysis of the global Injectable Bone Graft landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Injectable Bone Graft portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Injectable Bone Graft market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Injectable Bone Graft and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Injectable Bone Graft.

This report presents a comprehensive overview, market shares, and growth opportunities of Injectable Bone Graft market by product type, application, key players and key regions and countries.

Segmentation by Type:
Natural
Synthetic

Segmentation by Application:
Hospital
Clinic

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Medtronic
DePuy Synthes
Baxter
Stryker (Wright Medical)
BONESUPPORT
Xtant Medical
SeaSpine
Zimmer Biomet
Biocomposites
Anika
ORD
Biomatlante
Graftys

Please note: The report will take approximately 2 business days to prepare and deliver.